PMID-sentid Pub_year Sent_text compound_name comp_offset prot_official_name organism prot_offset 8166664-5 1994 Gangliosides, especially the GM3 ganglioside, but not other glycosphingolipids, inhibited the activity of the 39 kDa phospholipase A2 in a dose-dependent manner. G(M3) Ganglioside 29-44 LOC104974671 Bos taurus 117-133 1634229-3 1992 Labelled GM2 ganglioside accumulated in 4 variants of GM2 gangliosidosis, whereas labelled GM3 ganglioside accumulated in sialidosis, galactosialidoses and sphingolipid activator protein 1 (SAP-1, saposin B) and prosaposin (saposin A, B, C and D) deficient lipidoses. G(M3) Ganglioside 91-106 prosaposin Homo sapiens 156-188 8395211-2 1993 A specific plasma membrane glycosphingolipid, known as ganglioside GM3, can regulate the intrinsic tyrosyl kinase activity of the epidermal growth factor (EGF) receptor; this modulation is not associated with alterations in hormone binding to the receptor. G(M3) Ganglioside 55-70 epidermal growth factor receptor Homo sapiens 130-168 1634229-4 1992 The reduced degradation of GM3 ganglioside in the SAP-1 and prosaposin deficiencies was attributed to the deficient function of SAP-1. G(M3) Ganglioside 27-42 prosaposin Homo sapiens 50-55 1634229-4 1992 The reduced degradation of GM3 ganglioside in the SAP-1 and prosaposin deficiencies was attributed to the deficient function of SAP-1. G(M3) Ganglioside 27-42 prosaposin Homo sapiens 128-133 1998515-0 1991 Special considerations in the purification of the GM3 ganglioside-forming enzyme, CMP-sialic acid:lactosylceramide alpha 2-3 sialyltransferase (SAT-1): effects of protease inhibitors on rat hepatic SAT-1 activity. G(M3) Ganglioside 50-65 spermidine/spermine N1-acetyl transferase 1 Rattus norvegicus 144-149 1628323-6 1992 GM3 ganglioside also colocalized with vimentin in human fibroblasts. G(M3) Ganglioside 0-15 vimentin Homo sapiens 38-46 1999428-0 1991 Purification to apparent homogeneity by immunoaffinity chromatography and partial characterization of the GM3 ganglioside-forming enzyme, CMP-sialic acid:lactosylceramide alpha 2,3-sialyltransferase (SAT-1), from rat liver Golgi. G(M3) Ganglioside 106-121 ST3 beta-galactoside alpha-2,3-sialyltransferase 5 Rattus norvegicus 154-198 1999428-0 1991 Purification to apparent homogeneity by immunoaffinity chromatography and partial characterization of the GM3 ganglioside-forming enzyme, CMP-sialic acid:lactosylceramide alpha 2,3-sialyltransferase (SAT-1), from rat liver Golgi. G(M3) Ganglioside 106-121 spermidine/spermine N1-acetyl transferase 1 Rattus norvegicus 200-205 1999428-6 1991 SAT-1 specifically catalyzes the transfer of N-acetylneuraminic acid (NeuAc, sialic acid) to lactosylceramide (Gal beta 1-4Glc beta 1-O-ceramide), forming GM3 ganglioside. G(M3) Ganglioside 155-170 spermidine/spermine N1-acetyl transferase 1 Rattus norvegicus 0-5 1998515-0 1991 Special considerations in the purification of the GM3 ganglioside-forming enzyme, CMP-sialic acid:lactosylceramide alpha 2-3 sialyltransferase (SAT-1): effects of protease inhibitors on rat hepatic SAT-1 activity. G(M3) Ganglioside 50-65 spermidine/spermine N1-acetyl transferase 1 Rattus norvegicus 198-203 2222467-0 1990 Special considerations in the purification of the GM3 ganglioside forming enzyme, CMP-sialic acid:lactosylceramide alpha 2-3 sialyltransferase (SAT-1): solubilization of SAT-1 with lauryldimethylamine oxide. G(M3) Ganglioside 50-65 spermidine/spermine N1-acetyl transferase 1 Rattus norvegicus 144-149 2222467-0 1990 Special considerations in the purification of the GM3 ganglioside forming enzyme, CMP-sialic acid:lactosylceramide alpha 2-3 sialyltransferase (SAT-1): solubilization of SAT-1 with lauryldimethylamine oxide. G(M3) Ganglioside 50-65 spermidine/spermine N1-acetyl transferase 1 Rattus norvegicus 170-175 2222467-1 1990 Lauryldimethylamine oxide (LDAO) was employed in the purification of the GM3 ganglioside forming enzyme, CMP-sialic acid:lactosylceramide alpha 2-3 sialyltransferase (SAT-1) (4). G(M3) Ganglioside 73-88 spermidine/spermine N1-acetyl transferase 1 Rattus norvegicus 167-172 34539566-8 2021 Computational docking analysis disclosed the possible stabilizing effect of PFOA on the complex between InsR and GM3 ganglioside, previously shown to be associated with the low grade chronic inflammation-related insulin resistance. G(M3) Ganglioside 113-128 insulin receptor Homo sapiens 104-108 34592985-8 2021 NPC1-/- i3Neurons recapitulate cardinal cellular NPC1 pathological features including perinuclear endolysosomal storage of unesterified cholesterol, accumulation of GM2 and GM3 gangliosides, mitochondrial dysfunction, and impaired axonal lysosomal transport. G(M3) Ganglioside 173-189 NPC intracellular cholesterol transporter 1 Homo sapiens 0-4 34539566-8 2021 Computational docking analysis disclosed the possible stabilizing effect of PFOA on the complex between InsR and GM3 ganglioside, previously shown to be associated with the low grade chronic inflammation-related insulin resistance. G(M3) Ganglioside 113-128 insulin Homo sapiens 212-219 7291729-7 1981 Inhibition of beta-hexosaminidase and GM3-sialidase may explain the accumulation of GM2 and GM3 gangliosides in the brains of rats treated intracerebrally with suramin (Constantopoulos et al, 1980). G(M3) Ganglioside 92-108 O-GlcNAcase Rattus norvegicus 14-33 35228371-0 2022 (Homeostatic and Pathophysiological Regulation of Toll-like Receptor 4 Signaling by GM3 Ganglioside Molecular Species). G(M3) Ganglioside 84-99 toll like receptor 4 Homo sapiens 50-70 3768140-9 1986 The presence of a sialate O-acetylesterase acting on hematoside containing N-glycoloyl-4-O-acetylneuraminic acid was established. G(M3) Ganglioside 53-63 sialic acid acetylesterase Homo sapiens 18-42 7451473-4 1981 The incubation of platelets with thrombin resulted in a 50% reduction in the labeling of both trihexosylceramide and globoside and a 100% increase in labeling of hematoside on the platelet surface. G(M3) Ganglioside 162-172 coagulation factor II, thrombin Homo sapiens 33-41 991384-4 1976 It could be demonstrated that N-acetyl neuraminic acid residue of the total hematoside present in the virion is hydrolyzed by neuraminidase leaving the particles fully intact. G(M3) Ganglioside 76-86 neuraminidase 1 Homo sapiens 126-139 4701549-9 1973 Treatment of platelets with trypsin, chymotrypsin, or thrombin increased the yield of hematoside as compared with a control, while the level of ceramides was not changed. G(M3) Ganglioside 86-96 coagulation factor II, thrombin Homo sapiens 54-62 1141384-4 1975 Butyrate (5 mM) induces the sialyltransferase after a 4-h lag, producing maximum specific activity by 24 h. The amount of sialyl-lactosylceramide, the glycolipid product of the enzyme, increases during that time 3.5 times more than in control cultures. G(M3) Ganglioside 122-145 ST6 beta-galactoside alpha-2,6-sialyltransferase 2 Homo sapiens 28-45 33933428-0 2021 FRET detects lateral interaction between transmembrane domain of EGF receptor and ganglioside GM3 in lipid bilayers. G(M3) Ganglioside 82-97 epidermal growth factor receptor Homo sapiens 65-77 28001010-9 2017 In contrast, GM3 gangliosides, several ceramides, a triacylglycerol potentially containing arachidonate, and cholesteryl palmitate were downregulated by LBP KD. G(M3) Ganglioside 13-29 lipopolysaccharide binding protein Homo sapiens 153-156 28974375-1 2018 Tay-Sachs disease is a severe lysosomal storage disorder caused by mutations in Hexa, the gene that encodes for the alpha subunit of lysosomal beta-hexosaminidase A (HEXA), which converts GM2 to GM3 ganglioside. G(M3) Ganglioside 195-210 hexosaminidase A Mus musculus 80-84 28974375-1 2018 Tay-Sachs disease is a severe lysosomal storage disorder caused by mutations in Hexa, the gene that encodes for the alpha subunit of lysosomal beta-hexosaminidase A (HEXA), which converts GM2 to GM3 ganglioside. G(M3) Ganglioside 195-210 hexosaminidase A Mus musculus 166-170 33864399-4 2021 Mice that express only GM3 ganglioside (double knockout produced by crossing GalNAc-T-/- and GD3 synthase-/- mice, Dbl KO) display markedly accelerated neurodegeneration with reduced survival. G(M3) Ganglioside 23-38 ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 1 Mus musculus 93-105 33864399-4 2021 Mice that express only GM3 ganglioside (double knockout produced by crossing GalNAc-T-/- and GD3 synthase-/- mice, Dbl KO) display markedly accelerated neurodegeneration with reduced survival. G(M3) Ganglioside 23-38 mcf.2 transforming sequence Mus musculus 115-118 29196263-8 2018 Here, we confirm hypoxia-induced expression of the NeuGc GM3 ganglioside also in HeLa cells and reveal several candidate proteins, in particular GM3 synthase and subunit B of respiratory complex II (SDHB), that may be involved in the generation of NeuGc GM3 by SILAC-based proteome analysis. G(M3) Ganglioside 57-72 succinate dehydrogenase complex iron sulfur subunit B Homo sapiens 199-203 27172362-2 2016 It was shown for caveolin-rich adipocytes, that GM3 ganglioside binds to insulin receptor (IR), dissociates its complex with caveolin, and thus lowers IR autophosphorylation following insulin treatment. G(M3) Ganglioside 48-63 insulin receptor Homo sapiens 73-89 27449755-1 2016 Interaction between epidermal growth factor receptor (EGFR) signaling with GM3 ganglioside expression has been previously described. G(M3) Ganglioside 75-90 epidermal growth factor receptor Homo sapiens 20-52 27449755-1 2016 Interaction between epidermal growth factor receptor (EGFR) signaling with GM3 ganglioside expression has been previously described. G(M3) Ganglioside 75-90 epidermal growth factor receptor Homo sapiens 54-58 27626296-2 2016 GM-3 ganglioside, a widespread GSL, affects HIV entry and infection in different ways, depending on the concentration, through its anchoring activity in lipid rafts. G(M3) Ganglioside 0-16 cathepsin A Homo sapiens 31-34 27172362-0 2016 Glucosylceramide synthase inhibitors D-PDMP and D-EtDO-P4 decrease the GM3 ganglioside level, differ in their effects on insulin receptor autophosphorylation but increase Akt1 kinase phosphorylation in human hepatoma HepG2 cells. G(M3) Ganglioside 71-86 UDP-glucose ceramide glucosyltransferase Homo sapiens 0-25 27105818-0 2016 NEU3 inhibitory effect of naringin suppresses cancer cell growth by attenuation of EGFR signaling through GM3 ganglioside accumulation. G(M3) Ganglioside 106-121 neuraminidase 3 Homo sapiens 0-4 27105818-0 2016 NEU3 inhibitory effect of naringin suppresses cancer cell growth by attenuation of EGFR signaling through GM3 ganglioside accumulation. G(M3) Ganglioside 106-121 epidermal growth factor receptor Homo sapiens 83-87 27172362-2 2016 It was shown for caveolin-rich adipocytes, that GM3 ganglioside binds to insulin receptor (IR), dissociates its complex with caveolin, and thus lowers IR autophosphorylation following insulin treatment. G(M3) Ganglioside 48-63 insulin receptor Homo sapiens 91-93 27172362-2 2016 It was shown for caveolin-rich adipocytes, that GM3 ganglioside binds to insulin receptor (IR), dissociates its complex with caveolin, and thus lowers IR autophosphorylation following insulin treatment. G(M3) Ganglioside 48-63 insulin receptor Homo sapiens 151-153 26206186-6 2015 The pretreatment with 3-O-methylsphingomyelin (a neutral sphingomyelinase inhibitor) restored sphingomyelin levels together with the lactosylceramide and GM3 ganglioside levels and prevented the ER stress and cell death caused by the alpha-glycoside. G(M3) Ganglioside 154-169 sphingomyelin phosphodiesterase 2 Homo sapiens 49-73 25227752-10 2014 CONCLUSIONS: Associations of angiotensin IV, diphthamide, and GM3 gangliosides with CD implicate novel pathways in activating a Th1/Th17 inflammatory profile. G(M3) Ganglioside 62-78 negative elongation factor complex member C/D Homo sapiens 128-131 25313007-0 2015 Differential uPAR recruitment in caveolar-lipid rafts by GM1 and GM3 gangliosides regulates endothelial progenitor cells angiogenesis. G(M3) Ganglioside 65-81 plasminogen activator, urokinase receptor Homo sapiens 13-17 25462158-6 2015 In this study we investigated the localization of beta-hexosaminidase and beta-galactosidase glycohydrolases, both involved in step by step degradation of the GM1 to GM3 gangliosides, in lipid microdomains from the cortex of both an early and advanced TgCRND8 mouse model of Alzheimer"s disease. G(M3) Ganglioside 166-182 O-GlcNAcase Mus musculus 50-69 25462158-6 2015 In this study we investigated the localization of beta-hexosaminidase and beta-galactosidase glycohydrolases, both involved in step by step degradation of the GM1 to GM3 gangliosides, in lipid microdomains from the cortex of both an early and advanced TgCRND8 mouse model of Alzheimer"s disease. G(M3) Ganglioside 166-182 coenzyme Q10A Mus musculus 159-162 24399479-1 2014 We demonstrated the molecular pathogenesis of type 2 diabetes and insulin resistance focusing on the interaction between insulin receptor and GM3 ganglioside in adipocytes and propose a working hypothesis "metabolic disorders, such as type 2 diabetes, are membrane microdomain disorders caused by aberrant expression of gangliosides". G(M3) Ganglioside 142-157 insulin Homo sapiens 66-73 24399479-1 2014 We demonstrated the molecular pathogenesis of type 2 diabetes and insulin resistance focusing on the interaction between insulin receptor and GM3 ganglioside in adipocytes and propose a working hypothesis "metabolic disorders, such as type 2 diabetes, are membrane microdomain disorders caused by aberrant expression of gangliosides". G(M3) Ganglioside 142-157 insulin receptor Homo sapiens 121-137 22200571-1 2012 Previously, we demonstrated that an inhibitor of ganglioside biosynthesis, d-PDMP, could restore impaired insulin signaling in tumor necrosis factor alpha (TNFalpha)-treated adipocytes by blocking the increase of GM3 ganglioside. G(M3) Ganglioside 213-228 tumor necrosis factor Homo sapiens 127-154 24343103-3 2014 At the cellular level, deficiency in beta-glu activity leads to abnormal accumulation of glycosaminoglycans (GAGs), and secondary accumulation of GM2 and GM3 gangliosides, which have been linked to neuroinflammation. G(M3) Ganglioside 154-170 glucuronidase beta Canis lupus familiaris 37-45 23881911-8 2013 Intervention with miglustat in NPC1 patients was accompanied by striking alterations in plasma (reductions in GM1 and GM3 gangliosides) and cerebrospinal fluid (CSF) (increased MCs) sphingolipids. G(M3) Ganglioside 118-134 NPC intracellular cholesterol transporter 1 Homo sapiens 31-35 22990144-4 2013 GM3 synthase catalyzes the formation of GM3 ganglioside from lactosylceramide, which is the first step in the synthesis of complex ganglioside species. G(M3) Ganglioside 40-55 ST3 beta-galactoside alpha-2,3-sialyltransferase 5 Homo sapiens 0-12 21978926-5 2012 beta-hexosaminidase and beta-galactosidase cleave specific beta-linked terminal residues from a wide range of glycoconjugates and in particular are involved in the stepwise degradation of GM1 to GM3 ganglioside. G(M3) Ganglioside 195-210 O-GlcNAcase Homo sapiens 0-19 21978926-5 2012 beta-hexosaminidase and beta-galactosidase cleave specific beta-linked terminal residues from a wide range of glycoconjugates and in particular are involved in the stepwise degradation of GM1 to GM3 ganglioside. G(M3) Ganglioside 195-210 galactosidase beta 1 Homo sapiens 24-42 24136227-5 2013 Irrespective to the expression levels of DRs, a molecular interaction between ganglioside GM3, abundant in lymphoid cells, and DR4 was detected. G(M3) Ganglioside 78-93 TNF receptor superfamily member 10a Homo sapiens 127-130 22200571-1 2012 Previously, we demonstrated that an inhibitor of ganglioside biosynthesis, d-PDMP, could restore impaired insulin signaling in tumor necrosis factor alpha (TNFalpha)-treated adipocytes by blocking the increase of GM3 ganglioside. G(M3) Ganglioside 213-228 tumor necrosis factor Homo sapiens 156-164 21558756-0 2011 Physiopathological function of hematoside (GM3 ganglioside). G(M3) Ganglioside 31-41 granulocyte macrophage antigen 3 Mus musculus 43-46 21550404-1 2011 There is no treatment for the progressive neurodegenerative lysosomal storage disorder mucopolysaccharidosis type IIIA (MPS IIIA), which occurs due to a deficiency of functional N-sulfoglucosamine sulfohydrolase (SGSH), with subsequent accumulation of partially-degraded heparan sulfate and secondarily-stored compounds including GM2 and GM3 gangliosides and unesterified cholesterol. G(M3) Ganglioside 338-354 N-sulfoglucosamine sulfohydrolase Canis lupus familiaris 213-217 21575493-9 2011 CONCLUSIONS: Exogenous ganglioside GM3 can inhibit the proliferation, promote apoptosis, and down-regulate the VEGF expression level in A549 cells. G(M3) Ganglioside 23-38 vascular endothelial growth factor A Homo sapiens 111-115 19951433-11 2009 In vitro incubation of these NeuGc-negative cells with NeuGc-rich mucin increased the presence of NeuGc in cell membranes for at least 48-72 h, as a component of the GM3 ganglioside. G(M3) Ganglioside 166-181 mucin 1, cell surface associated Bos taurus 66-71 20156584-9 2010 Altogether, although the involvement of other ganglioside species cannot be excluded, these findings sustain the ganglioside GM(3) as an essential molecule for EGFR/ErbB2 heterodimer stability and important regulator of EGFR tyrosine phosphorylation, but it is not crucial for tyrosine phosphorylation of the heterodimerization partner ErbB2. G(M3) Ganglioside 113-130 epidermal growth factor receptor Homo sapiens 160-164 20156584-9 2010 Altogether, although the involvement of other ganglioside species cannot be excluded, these findings sustain the ganglioside GM(3) as an essential molecule for EGFR/ErbB2 heterodimer stability and important regulator of EGFR tyrosine phosphorylation, but it is not crucial for tyrosine phosphorylation of the heterodimerization partner ErbB2. G(M3) Ganglioside 113-130 erb-b2 receptor tyrosine kinase 2 Homo sapiens 165-170 20156584-9 2010 Altogether, although the involvement of other ganglioside species cannot be excluded, these findings sustain the ganglioside GM(3) as an essential molecule for EGFR/ErbB2 heterodimer stability and important regulator of EGFR tyrosine phosphorylation, but it is not crucial for tyrosine phosphorylation of the heterodimerization partner ErbB2. G(M3) Ganglioside 113-130 epidermal growth factor receptor Homo sapiens 220-224 20156584-9 2010 Altogether, although the involvement of other ganglioside species cannot be excluded, these findings sustain the ganglioside GM(3) as an essential molecule for EGFR/ErbB2 heterodimer stability and important regulator of EGFR tyrosine phosphorylation, but it is not crucial for tyrosine phosphorylation of the heterodimerization partner ErbB2. G(M3) Ganglioside 113-130 erb-b2 receptor tyrosine kinase 2 Homo sapiens 336-341 18820643-1 2009 In chronic myeloid leukemia K562 cells, differentiation is also blocked because of low levels of ganglioside GM3, derived by the high expression of sialidase Neu3 active on GM3. G(M3) Ganglioside 97-112 neuraminidase 3 Homo sapiens 158-162 19056848-7 2009 Histological studies and lipid analysis of brain sections indicated that the NP-C mice carrying the Rab9 transgene had dramatically reduced storage of GM(2) and GM(3) gangliosides relative to NP-C animals lacking the transgene. G(M3) Ganglioside 161-179 RAB9, member RAS oncogene family Mus musculus 100-104 18828994-1 2008 EGF-induced activation of EGFR tyrosine kinase is known to be inhibited by ganglioside GM3, its dimer, and other mimetics. G(M3) Ganglioside 75-90 epidermal growth factor receptor Homo sapiens 26-30 18310617-0 2008 Differential influence of the tumour-specific non-human sialic acid containing GM3 ganglioside on CD4+CD25- effector and naturally occurring CD4+CD25+ regulatory T cells function. G(M3) Ganglioside 79-94 CD4 molecule Homo sapiens 98-101 18310617-0 2008 Differential influence of the tumour-specific non-human sialic acid containing GM3 ganglioside on CD4+CD25- effector and naturally occurring CD4+CD25+ regulatory T cells function. G(M3) Ganglioside 79-94 interleukin 2 receptor subunit alpha Homo sapiens 102-106 15939439-9 2005 These results provide a pathophysiological link between mesangial cell proliferation and ganglioside GM3 expression, indicating that exogenously added ganglioside GM3 inhibits the high-ambient glucose- and TGF-beta1-induced proliferation of cultured GMCs. G(M3) Ganglioside 89-104 transforming growth factor, beta 1 Rattus norvegicus 206-215 17577665-2 2008 The gangliosideGM3, is a non-specific inhibitor of EGF receptor autophosphorylation (EGFR-phos). G(M3) Ganglioside 4-18 epidermal growth factor receptor Rattus norvegicus 85-89 17142315-2 2006 Ligand-dependent activation of EGFR tyrosine kinase is known to be inhibited by ganglioside GM3, but to a much lesser degree by other glycosphingolipids. G(M3) Ganglioside 80-95 epidermal growth factor receptor Homo sapiens 31-35 16574813-6 2006 Additionally, ganglioside GM3 enhances expression of CKI p27(kip1) through the PTEN-mediated inhibition of the PI-3K/AKT signaling. G(M3) Ganglioside 14-29 choline kinase alpha Homo sapiens 53-56 16574813-6 2006 Additionally, ganglioside GM3 enhances expression of CKI p27(kip1) through the PTEN-mediated inhibition of the PI-3K/AKT signaling. G(M3) Ganglioside 14-29 interferon alpha inducible protein 27 Homo sapiens 57-60 16574813-6 2006 Additionally, ganglioside GM3 enhances expression of CKI p27(kip1) through the PTEN-mediated inhibition of the PI-3K/AKT signaling. G(M3) Ganglioside 14-29 cyclin dependent kinase inhibitor 1B Homo sapiens 61-65 16574813-6 2006 Additionally, ganglioside GM3 enhances expression of CKI p27(kip1) through the PTEN-mediated inhibition of the PI-3K/AKT signaling. G(M3) Ganglioside 14-29 phosphatase and tensin homolog Homo sapiens 79-83 16574813-6 2006 Additionally, ganglioside GM3 enhances expression of CKI p27(kip1) through the PTEN-mediated inhibition of the PI-3K/AKT signaling. G(M3) Ganglioside 14-29 AKT serine/threonine kinase 1 Homo sapiens 117-120 16538029-5 2006 Following treatment with RANKL, ganglioside GM3 and GM1 were increased in the treated bone marrow cells, whereas other types were not detected using thin layer chromatography analysis. G(M3) Ganglioside 32-47 TNF superfamily member 11 Homo sapiens 25-30 15939439-0 2005 Ganglioside GM3 inhibits the high glucose- and TGF-beta1-induced proliferation of rat glomerular mesangial cells. G(M3) Ganglioside 0-15 transforming growth factor, beta 1 Rattus norvegicus 47-56 16208470-0 2006 Role of tumour-associated N-glycolylated variant of GM3 ganglioside in cancer progression: effect over CD4 expression on T cells. G(M3) Ganglioside 52-67 CD4 molecule Homo sapiens 103-106 11447130-0 2001 Epidermal growth factor receptor glycosylation is required for ganglioside GM3 binding and GM3-mediated suppression [correction of suppresion] of activation. G(M3) Ganglioside 63-78 Epidermal growth factor receptor Drosophila melanogaster 0-32 12641744-6 2003 Remarkably, TAG-1 was cross-linked in a similar extent by the photoactivated ganglioside GM3, GM1 and GD1b. G(M3) Ganglioside 77-92 contactin 2 Homo sapiens 12-17 12068006-0 2002 Tetraspanin CD9 is a "proteolipid," and its interaction with alpha 3 integrin in microdomain is promoted by GM3 ganglioside, leading to inhibition of laminin-5-dependent cell motility. G(M3) Ganglioside 108-123 CD9 antigen Cricetulus griseus 12-15 12068006-1 2002 GM3 ganglioside inhibits tetraspanin CD9-facilitated cell motility in various cell lines (Ono, M., Handa, K., Sonnino, S., Withers, D. A., Nagai, H., and Hakomori, S. (2001) Biochemistry 40, 6414-6421). G(M3) Ganglioside 0-15 CD9 antigen Cricetulus griseus 37-40 12145192-3 2002 The aim of the study was to analyze the mode of action of the lactone of the ganglioside GM3 on epidermal growth factor (EGF) signaling in human ovarial epidermoid carcinoma A431 cells and cell growth in human oral epidermoid carcinoma KB cells by applying the GM3 lactone analog HK1-ceramide 2, which is stable under hydrolytic conditions. G(M3) Ganglioside 77-92 hexokinase 1 Homo sapiens 280-283 11707432-2 2002 We have found that insulin resistance induced by tumor necrosis factor-alpha (TNF-alpha) in 3T3-L1 adipocytes was accompanied by increased GM3 ganglioside expression caused by elevating GM3 synthase activity and its mRNA. G(M3) Ganglioside 139-154 tumor necrosis factor Rattus norvegicus 49-76 11707432-2 2002 We have found that insulin resistance induced by tumor necrosis factor-alpha (TNF-alpha) in 3T3-L1 adipocytes was accompanied by increased GM3 ganglioside expression caused by elevating GM3 synthase activity and its mRNA. G(M3) Ganglioside 139-154 tumor necrosis factor Rattus norvegicus 78-87 11707432-2 2002 We have found that insulin resistance induced by tumor necrosis factor-alpha (TNF-alpha) in 3T3-L1 adipocytes was accompanied by increased GM3 ganglioside expression caused by elevating GM3 synthase activity and its mRNA. G(M3) Ganglioside 139-154 ST3 beta-galactoside alpha-2,3-sialyltransferase 5 Rattus norvegicus 186-198 11591370-4 2001 These findings reveal that gp120 binding induces a strict association between CXCR4 and ganglioside GM3, supporting the view that GM3 and CXCR4 are components of a functional multimolecular complex critical for HIV-1 entry. G(M3) Ganglioside 88-103 Envelope surface glycoprotein gp160, precursor Human immunodeficiency virus 1 27-32 11591370-4 2001 These findings reveal that gp120 binding induces a strict association between CXCR4 and ganglioside GM3, supporting the view that GM3 and CXCR4 are components of a functional multimolecular complex critical for HIV-1 entry. G(M3) Ganglioside 88-103 C-X-C motif chemokine receptor 4 Homo sapiens 78-83 11591370-4 2001 These findings reveal that gp120 binding induces a strict association between CXCR4 and ganglioside GM3, supporting the view that GM3 and CXCR4 are components of a functional multimolecular complex critical for HIV-1 entry. G(M3) Ganglioside 88-103 C-X-C motif chemokine receptor 4 Homo sapiens 138-143 15385432-6 2005 On the other hand, although ganglioside GM3 was shown to be able to induce the differentiation of HL-60 cells into the monocyte/macrophage lineage, effect of ganglioside GM3 on expression of CD11b as a differentiation marker in HL-60 cells has been not reported yet. G(M3) Ganglioside 158-173 integrin subunit alpha M Homo sapiens 191-196 12032173-0 2002 Ganglioside GM3 activates ERKs in human lymphocytic cells. G(M3) Ganglioside 0-15 mitogen-activated protein kinase 1 Homo sapiens 26-30 11201791-6 2000 Using this approach, we identified globotriaosylceramide (Gb3) and ganglioside GM3 as the main lymphocyte GSL recognized by gp120. G(M3) Ganglioside 67-82 inter-alpha-trypsin inhibitor heavy chain 4 Homo sapiens 124-129 11371204-0 2001 GM3 ganglioside inhibits CD9-facilitated haptotactic cell motility: coexpression of GM3 and CD9 is essential in the downregulation of tumor cell motility and malignancy. G(M3) Ganglioside 0-15 CD9 antigen Cricetulus griseus 25-28 11371204-0 2001 GM3 ganglioside inhibits CD9-facilitated haptotactic cell motility: coexpression of GM3 and CD9 is essential in the downregulation of tumor cell motility and malignancy. G(M3) Ganglioside 0-15 CD9 antigen Cricetulus griseus 92-95 11440194-0 2001 Coupling of nerve growth factor to its receptor: inhibition by anti-GM3 ganglioside antibody. G(M3) Ganglioside 68-83 nerve growth factor Rattus norvegicus 12-31 11440194-4 2001 An antibody against GM3 ganglioside was found to inhibit the nerve growth factor mediated neurite formation of both the cells in vitro significantly. G(M3) Ganglioside 20-35 nerve growth factor Rattus norvegicus 61-80 10428836-7 1999 The mitochondrial effects of GD3 ganglioside are selective, in that they cannot be mimicked by either GD1a or GM3 gangliosides, and they are fully sensitive to cyclosporin A, which inhibits both the mitochondrial permeability transition in situ and the onset of apoptosis induced by GD3 ganglioside. G(M3) Ganglioside 110-126 GRDX Homo sapiens 29-32 10527410-4 1999 Fibrinogen interacted minimally with phosphatidylinositol, and not at all with pure phosphatidylcholine (PC) or PC vesicles containing 5% glycosphingolipid (lactosylceramide, ganglioside GM3, ganglioside GD3). G(M3) Ganglioside 175-190 fibrinogen beta chain Homo sapiens 0-10 10233996-3 1999 We identified globotriaosylceramide (Gb3) and ganglioside GM3 as the main glycosphingolipids recognized by gp120. G(M3) Ganglioside 46-61 inter-alpha-trypsin inhibitor heavy chain 4 Homo sapiens 107-112 9600078-0 1998 Sequential interaction of CD4 and HIV-1 gp120 with a reconstituted membrane patch of ganglioside GM3: implications for the role of glycolipids as potential HIV-1 fusion cofactors. G(M3) Ganglioside 85-100 CD4 molecule Homo sapiens 26-29 9600078-0 1998 Sequential interaction of CD4 and HIV-1 gp120 with a reconstituted membrane patch of ganglioside GM3: implications for the role of glycolipids as potential HIV-1 fusion cofactors. G(M3) Ganglioside 85-100 Envelope surface glycoprotein gp160, precursor Human immunodeficiency virus 1 40-45 8840162-0 1996 Differential modulation of basic fibroblast and epidermal growth factor receptor activation by ganglioside GM3 in cultured retinal Muller glia. G(M3) Ganglioside 95-110 epidermal growth factor receptor Homo sapiens 48-80 8840162-3 1996 These glial cells readily incorporated exogenously administered GM3 ganglioside, which was not substantially metabolized within 24 h. Such treatments significantly inhibited bFGF-induced DNA replication and cell migration, while having much less effect on analogous EGF-mediated behaviors. G(M3) Ganglioside 64-79 fibroblast growth factor 2 Homo sapiens 174-178